Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-177017
Filing Date
2025-08-08
Accepted
2025-08-08 16:27:13
Documents
15
Effectiveness Date
2025-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 d933616ds8.htm S-8 43418
2 EX-5.1 d933616dex51.htm EX-5.1 9380
3 EX-23.1 d933616dex231.htm EX-23.1 2056
4 EX-FILING FEES d933616dexfilingfees.htm   iXBRL EX-FILING FEES 12323
5 GRAPHIC g933616g0807072735907.jpg GRAPHIC 2534
  Complete submission text file 0001193125-25-177017.txt   190259

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d933616dexfilingfees_htm.xml XML 4692
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289433 | Film No.: 251198824
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)